BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28804991)

  • 1. NF-κB2 Controls the Migratory Activity of Memory T Cells by Regulating Expression of CXCR4 in a Mouse Model of Sjögren's Syndrome.
    Kurosawa M; Arakaki R; Yamada A; Tsunematsu T; Kudo Y; Sprent J; Ishimaru N
    Arthritis Rheumatol; 2017 Nov; 69(11):2193-2202. PubMed ID: 28804991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
    Hansen A; Reiter K; Ziprian T; Jacobi A; Hoffmann A; Gosemann M; Scholze J; Lipsky PE; Dörner T
    Arthritis Rheum; 2005 Jul; 52(7):2109-19. PubMed ID: 15986367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor repertoire of infiltrating T cells in lachrymal glands, salivary glands and kidneys from alymphoplasia (aly) mutant mice: a new model for Sjögren's syndrome.
    Furukawa M; Sakamoto A; Kita Y; Ohishi Y; Matsumura R; Tsubata R; Tsubata T; Iwamoto I; Saito Y; Sumida T
    Br J Rheumatol; 1996 Dec; 35(12):1223-30. PubMed ID: 9010048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice.
    Kurosawa M; Shikama Y; Furukawa M; Arakaki R; Ishimaru N; Matsushita K
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjögren's syndrome.
    Tsubata R; Tsubata T; Hiai H; Shinkura R; Matsumura R; Sumida T; Miyawaki S; Ishida H; Kumagai S; Nakao K; Honjo T
    Eur J Immunol; 1996 Nov; 26(11):2742-8. PubMed ID: 8921964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1.
    Kew RR; Penzo M; Habiel DM; Marcu KB
    J Immunol; 2012 Mar; 188(5):2380-6. PubMed ID: 22287708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
    Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
    J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome.
    Ushio A; Arakaki R; Otsuka K; Yamada A; Tsunematsu T; Kudo Y; Aota K; Azuma M; Ishimaru N
    Front Immunol; 2018; 9():2594. PubMed ID: 30467506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired chemokine-induced migration during T-cell development in the absence of Jak 3.
    Soldevila G; Licona I; Salgado A; Ramírez M; Chávez R; García-Zepeda E
    Immunology; 2004 Jun; 112(2):191-200. PubMed ID: 15147562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis.
    Kohler RE; Comerford I; Townley S; Haylock-Jacobs S; Clark-Lewis I; McColl SR
    Brain Pathol; 2008 Oct; 18(4):504-16. PubMed ID: 18422759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritis.
    Brunn A; Utermöhlen O; Mihelcic M; Sánchez-Ruiz M; Carstov M; Blau T; Ustinova I; Penfold M; Montesinos-Rongen M; Deckert M
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):772-87. PubMed ID: 23452257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome.
    Xu J; Wang D; Liu D; Fan Z; Zhang H; Liu O; Ding G; Gao R; Zhang C; Ding Y; Bromberg JS; Chen W; Sun L; Wang S
    Blood; 2012 Oct; 120(15):3142-51. PubMed ID: 22927248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter.
    Peng B; Ling J; Lee AJ; Wang Z; Chang Z; Jin W; Kang Y; Zhang R; Shim D; Wang H; Fleming JB; Zheng H; Sun SC; Chiao PJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15193-8. PubMed ID: 20696914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
    Haneji N; Hamano H; Yanagi K; Hayashi Y
    J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
    Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
    PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system.
    Dotan I; Werner L; Vigodman S; Weiss S; Brazowski E; Maharshak N; Chen O; Tulchinsky H; Halpern Z; Guzner-Gur H
    Inflamm Bowel Dis; 2010 Apr; 16(4):583-92. PubMed ID: 19774645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Sjögren's syndrome and deficiency of ICA69.
    Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
    Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.